CFH rs1065489: What Your Genotype Means

What each genotype means

Understanding the rs1065489 Variant

The rs1065489 variant is a single-nucleotide polymorphism (SNP) located within the CFH gene on chromosome 1. In genetic terms, this variant represents a missense mutation, specifically identified as p.Glu936Asp, where the amino acid glutamic acid is replaced by aspartic acid in the resulting protein. Because this change occurs in the coding region of the gene, it has the potential to alter the structure or function of the protein it encodes. Scientists track this specific location to understand how variations in our DNA sequence contribute to complex health traits. While many SNPs are neutral, those that change the amino acid sequence of a protein are often prioritized in research to determine if they play a functional role in disease susceptibility or physiological processes.

The Role of the CFH Gene

The CFH gene provides instructions for making a protein called complement factor H. This protein is a critical component of the complement system, which is part of the body's innate immune response. Complement factor H acts as a regulator, preventing the complement system from becoming overactive and damaging the body's own healthy tissues. By circulating in the bloodstream, it helps distinguish between foreign invaders, like bacteria, and the body's own cells. When the CFH gene is altered, the resulting protein may not function as effectively, potentially leading to chronic inflammation or the accumulation of cellular debris. In the context of the eye, this dysfunction is thought to contribute to the development of drusen, which are small yellow deposits under the retina that are a hallmark of age-related macular degeneration.

Research and Clinical Associations

Research into rs1065489 has primarily focused on its association with neovascular age-related macular degeneration (AMD). Studies have suggested that this variant may influence an individual's susceptibility to the disease and, notably, their therapeutic response to anti-VEGF treatments. Anti-VEGF medications are commonly used to reduce abnormal blood vessel growth in the eye, but clinical outcomes can vary significantly between patients. Some evidence indicates that carriers of certain alleles at this locus may experience poorer responses to these therapies. However, it is important to note that the evidence strength for this association is considered moderate. Genetic associations are statistical in nature and do not guarantee that an individual will develop a condition or respond to a treatment in a specific way. Other genetic and environmental factors also play significant roles in AMD progression.

Population Frequency

The frequency of the rs1065489 variant varies across different ancestral groups. Current data indicates that the minor allele frequency for this SNP typically ranges between 0.08 and 0.15 in both Asian and European populations. Because this variant is relatively common, it is frequently studied in large-scale genomic research to better understand its distribution and impact. Genetic frequency data is essential for researchers to determine if a variant is rare or common within a specific population, which helps in assessing its potential contribution to the overall genetic architecture of a trait. If you are concerned about your genetic risk or how a specific variant might affect your health, it is essential to discuss these findings with a qualified clinician or a genetic counselor who can provide context based on your personal and family medical history.

Navigating Your Genetic Information

Learning about your genotype for rs1065489 can be an educational experience, but it is important to approach this information with a clear understanding of its limitations. Genetic testing provides a snapshot of your DNA, but it does not provide a medical diagnosis. Many factors, including lifestyle, diet, and other genetic variants, contribute to the risk of complex conditions like AMD. If you have received results regarding this variant, do not make any changes to your medical care or treatment plans based on this information alone. Always consult with your ophthalmologist or primary care physician to discuss how your genetic profile might relate to your eye health. They are the best resource for interpreting these results in the context of your overall health and for guiding you through any necessary clinical decisions or monitoring.

Frequently asked questions

Sources & further reading

Related variants in CFH